SCHEMBL8874259

SCHEMBL8874259

C[C@@H](C(=O)OCc1ccccc1)C1CCCCC1

nearest known ligand 0.57

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.57
CYP2C9 P11712 1/20 0.57
CYP2C19 P33261 1/20 0.57
ALDH1A1 P00352 4/20 0.52
EPHX1 P07099 1/20 0.51
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.49
EPHX2 P34913 3/20 0.47
TSHR P16473 2/20 0.47
GAA P10253 1/20 0.47
SIGMAR1 Q99720 1/20 0.46
SGMS2 Q8NHU3 1/20 0.46
FKBP1A P62942 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25597428 0.98 CYP3A4 (0.58) CYP3A4CYP2C9CYP2C19ALDH1A1EPHX1
SCHEMBL7495571 0.95 CYP3A4 (0.58) CYP3A4CYP2C9CYP2C19ALDH1A1EPHX1
SCHEMBL28085540 0.92 ALDH1A1 (0.55) CYP3A4CYP2C9CYP2C19ALDH1A1MEN1
SCHEMBL14092284 0.92 ALDH1A1 (0.55) CYP3A4CYP2C9CYP2C19ALDH1A1MEN1
SCHEMBL24835914 0.86 CYP2C19 (0.49) CYP3A4CYP2C9CYP2C19ALDH1A1MEN1
SCHEMBL8235638 0.86 CYP3A4 (0.56) CYP3A4CYP2C9CYP2C19ALDH1A1EPHX1
Hydrochloric Acid SCHEMBL1414260 0.85 CYP3A4 (0.54) CYP3A4CYP2C9CYP2C19ALDH1A1EPHX1
SCHEMBL27255245 0.85 KMT2A (0.50) CYP3A4CYP2C9CYP2C19ALDH1A1MEN1
SCHEMBL23867554 0.85 ALDH1A1 (0.58) CYP3A4CYP2C9CYP2C19ALDH1A1KMT2A
SCHEMBL21274374 0.84 CYP3A4 (0.57) CYP3A4CYP2C9CYP2C19ALDH1A1EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5610153-A ENZYME INHIBITORS; TREATMENT OF VASCULAR PROLIFERATION DISORDERS, STERILITY DYSFUNCTION, DYSMENORRHEA CIBA-GEIGY CORPORATION (US) 1997-03-11 US disclosed